BackCalliditas Therapeutics AB (publ) Overview

Calliditas Therapeutics AB (publ) Receivables

Track Calliditas Therapeutics AB (publ)'s receivables ($320K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$317131.00

Peer trimmed avg / median

Loading

Calliditas Therapeutics AB (publ) Receivables History

Loading

Calliditas Therapeutics AB (publ) vs. peers: Receivables Comparison

Loading

Calliditas Therapeutics AB (publ) Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Calliditas Therapeutics AB (publ) (CALTX.ST) FAQ

Calliditas Therapeutics AB (publ) (CALTX.ST) currently reports a receivables of $320K as of May 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Calliditas Therapeutics AB (publ)'s receivables history and peer comparisons.

Calliditas Therapeutics AB (publ)'s receivables changed from $0 to $320K (period ending May 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Calliditas Therapeutics AB (publ) reported $320K in receivables as of May 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $320K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Calliditas Therapeutics AB (publ), and consider following CALTX.ST for alerts when major investors trade the stock.

Calliditas Therapeutics AB (publ) is classified in the Healthcare sector. On receivables, it currently shows $320K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CALTX.ST with unrelated industries.